Michael Judge
Papers
2
Total Citations
10
H-Index
2
About
Michael Judge is a radiation oncology physicist whose research focuses on advancing stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), particularly through robotic delivery platforms. His major contributions lie in optimizing treatment planning parameters to improve dose homogeneity and plan quality in robotic radiosurgery. In his most-cited work (2021, 8 citations), Judge systematically investigated how prescription isodose levels and collimator selection physically constrain the ability to achieve intended dose distributions, providing critical guidance for clinical implementation. His subsequent work (2023, 2 citations) examined the efficacy and toxicity of robotic SBRT for lung metastases in oligometastatic disease, identifying factors that determine treatment success. These studies directly impact how clinicians balance tumor control with normal tissue sparing in complex cases. Judge’s research is particularly valuable for medical physicists and radiation oncologists seeking to refine robotic radiosurgery protocols, as it bridges the gap between physical dose delivery limitations and clinical outcomes. His work contributes to the growing evidence base supporting personalized, high-precision radiotherapy in the management of metastatic disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2